Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Simvastatin as a Neuroprotective Treatment for Parkinson's Disease: a Double-blind, Randomised, Placebo Controlled Futility Study in Patients of Moderate Severity.

NCT02787590 is registered in ClinicalTrials.gov with University Hospital Plymouth NHS Trust as lead sponsor.

NCT NCT02787590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02787590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Simvastatin as a Neuroprotective Treatment for Parkinson's Disease: a Double-blind, Randomised, Placebo Controlled Futility Study in Patients of Moderate Severity.
Lead sponsor
University Hospital Plymouth NHS Trust
Phase
Phase 2
Overall status
Completed
Start date
March 8, 2016
Completion date
December 31, 2020
Enrollment
235 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease